Publication | Closed Access
Pangenotypic direct‐acting antiviral agents for mixed genotype hepatitis C infection: A real‐world effectiveness analysis
10
Citations
17
References
2021
Year
Pangenotypic DAAs are well tolerated by and yield high SVR rates in patients with mixed genotype HCV infection.
| Year | Citations | |
|---|---|---|
Page 1
Page 1